Science, Politics, and the Pharmaceutical Industry: Controversy and Bias in Drug RegulationBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7012.1101a (Published 21 October 1995) Cite this as: BMJ 1995;311:1101
- Joe Collier
John Abraham UCL Press, pounds sterling12.95, pp 308 ISBN 1 85728 200 0
John Abraham's book on the relationship between the regulators and the pharmaceutical industry is a classic. For years there have been suspicions, and even allegations, that all too often those responsible for regulating the licensing and marketing of drugs have favoured the interests of manufacturers rather than those of the consumer. Hard data were often sparse—in the United Kingdom not least because of the excessive secrecy surrounding licensing.
Sometimes the special relationship was obvious; what other explanation could there be for the way the Department of Health (now the Medicines Control …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial